Modern techniques open horizons for the treatment of Parkinson patients

Some people with Parkinson disease (Parkinson’s) can complete the drug treatments with surgery, through a technique called ‘deep stimulation of the brain’, in an effective but stressful process that can be an accelerated development thanks to technology advance. Jean -louis Doflo, 63, who is the head of the France Parkinson Foundation, talks about his ‘resurrection’ 4 years after undergoing surgery. “I knew I would not recover because the disease continues to develop, but it enabled me to restore the movements of daily life,” he says. Doflo is one of the 10% of Parkinson patients who celebrate their international day on Thursday, who accept their body to undergo such a process. In the 1990s, a French team from Grenoble in the middle of the country discovered that the deep stimulation of the brain, which is the core under the mulch, has a major therapeutic effect against the symptoms of this disease. Since then, thousands of patients around the world have been treated, with a significant decline in their disorders, including tremors, stiffness and slow movements. Long -term studies have shown that the beneficial effect lasts for at least ten years in most patients. The technique is based on the transplantation of two electrical poles in the brain to stimulate the subcutaneous nuclei with a weak electric current. The reduction of symptoms of electric poles linked to a box that contains a battery planted under the skin, and sends pulses that restores the natural performance of the dopamine -based nerve networks, which control motor skills in particular. According to the World Health Organization, the process does not treat more than 8.5 million people worldwide in 2019, but it is part of a set of decisive therapeutic options to reduce symptoms. Medicine, which is used as a first option, is compensated for dopamine deficiency. But after 5 to 10 years, complications appear, with different stages in which symptoms vary with their strength, reflecting the differences in the effectiveness of treatment throughout the day. Here, deep stimulation of the brain can play a role, as qualified patients enable the effectiveness of medicine. The ‘ideal’ candidate for this treatment should be relatively small (less than 70 years), and he should not have large cognitive disorders or have no disorders that still respond to the treatment. Certainly, “This operation, performed in only 20 centers in France, has long been a very heavy surgical procedure,” according to a neurosurgeon at Amian University Hospital in Northern France, Michel Lovran. However, modern technological developments change the situation, as “progress in the field of photography enables the optimal target of electrical poles,” according to Lovran. 400 patients annually in his department can export the use of programs that create a digital twin for the patient’s brain, three -dimensional simulations before surgical intervention, which provides patients with long and exhausting motor tests. In Amian University Hospital, the operation is currently continuing less than 4 hours, followed by a hospital on average 5 days, compared to 10 hours of surgery and hospital accommodation for 15 to 21 days a few years ago. “The intervention occurs on a completely sleeping patient, which greatly improves his comfort.” “The operation has been updated, and we can give up from neurological physiological surveys in the operating room,” says Mark Zanilo, and we can give up neurological physiological surveys in the operating room, adding and adding: “We must currently publish innovation in all centers, which can treat more patients.” French Public Health Organization, 175,000 people were monitored for this disease in 2020. Work was also undertaken to reach a stimulus that is only operated according to the patient’s needs. Neurosurgeon at La Timon Hospital in Marseille.